Tove Wästerlid
About me
I am a board certified Haematologist at the Karolinska University Hospital and associate professor in haematology at Karolinska Institutet. I finished my PhD-studies at the Department of Oncology, Lund University, in 2016 and I have been active in lymphoma research since 2010. In September 2017 I joined the Cancer Epidemiology group [1] at KEP as a post-doc and am now a part of Professor Karin Ekström Smedby's research group as an associate professor since 2025.
2014: MD, Lund University
2016: PhD, Lund University, Thesis title: Burkitt lymphoma and diffuse large
B-cell lymphoma – therapeutic strategies and pathogenetic mechanisms
2017: Post-doc, Karolinska Institutet
2023: Specialist in Haematology2025: Associate professor (docent) in haematology
[1] https://ki.se/en/meds/kep-cancer-epidemiology
Research
My research focus is on malignant lymphomas, with a special interest in aggressive subtypes such as diffuse large B-cell lymphoma, Burkitt
lymphoma and primary mediastinal B-cell lymphoma. By using real-world data from national lymphoma registers linked to other databases I investigate the impact of prognostic factors, treatment and outcomes among patients with lymphoma in a population-based setting. I have several ongoing collaborative projects within the Nordic lymphoma group, to increase power to enable study of rare lymphoma subtypes.
I also have an interest in precision medicine and tumour biology and am one of the main organisers of the clinical, prospective study BioLymph. Biolymph is a collaborative project between the department of haematology, pathology and clinical genetics that prospectively collects tumour- and blood samples for all patients with newly diagnosed lymphomas at the Karolinska University hospital. Genomic sequencing is performed on tumour material and longitudinally on circulating cell-free tumour DNA (ctDNA), a promising tool to measure minimal residual disease in lymphoma. The aim of this research is to increase knowledge of the impact of genetic aberrations on prognosis and response to treatment and the ability of ctDNA to assess treatment response and detect relapse. The ultimate goal is for these precision medicine methods to be implemented in clinical practice to enable individualised treatment for all lymphoma patients to ultimately improve survival for patients with lymphoma. Currently, more than 550 patients are enrolled with inclusion ongoing.
I also participate as principal- and co-investigator in several ongoing clinical trials at the department of Haematology.
Teaching
- Main supervisor to doctoral student Johanna Borg Bruchfeld with the project
title "Sex-related differences in incidence and outcomes among patients with
lymphoma: epidemiological and biological perspectives"
Co-supervisor to doctoral student Joel Joelsson with the project title
"Second malignancies after non-Hodgkin lymphoma diagnosis and early
identification of patients with poor outcomes"
Co-supervisor to doctoral student Linn Deleskog Spångberg with the project
title "Long-term outcome and prognostic factors in follicular lymphoma and
Hodgkin lymphoma - population-based studies using registers and new precision
medicine biomarkers"
Co-supervisor to post-doc Erik Boberg with the project "Epidemiological studies on risk factors, survival, and survivorship in patients with acute lymphoblastic leukaemia"
Organiser of Epidemiology Courses during Block II & IV in NatiOn: National
Research School in Clinical and Translational Cancer Research
Organiser of the annual Young Researchers in Hematology Conference at
Karolinska Institutet
Mentor at the course in professional development for medical student at
Karolinska institutet since 2017
Articles
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2025Liu X; Adami H-O; Wasterlid T; Xue H; Feychting M; Smedby KE; Fang F; Liu Q
- Article: JOURNAL OF INTERNAL MEDICINE. 2025;297(6):672-682Liu Q; Wasterlid T; Smedby KE; Xue H; Boberg E; Fang F; Liu X
- Article: HEALTH INFORMATICS JOURNAL. 2024;30(4):14604582241290725Brahimllari O; Eloranta S; Georgii-Hemming P; Haider Z; Koch S; Krstic A; Skarp FP; Rosenquist R; Smedby KE; Taylan F; Thorvaldsdottir B; Wirta V; Wasterlid T; Boman M
- Article: ECLINICALMEDICINE. 2024;74:102753Liu Q; Smedby KE; Xue H; Waesterlid T; Li J; Fang F; Liu X
- Article: ACTA ONCOLOGICA. 2024;63:563-572Smedby KE; Eloranta S; Wasterlid T; Falini V; Jerlstrom U; Ellin F; Papworth K; Westerberg J; Lewerin C; Andersson P-O; Kristjansdottir HL; Brandefors L; Morth C-L; Hallen K; Kuric N; Abu Sabaa A; Wahlin BE; Molin D; Enblad G; Horsted A-S; Jerkeman M; Glimelius I
- Article: EJHAEM. 2024;5(3):516-526Wasterlid T; Dietrich CE; Oksanen A; Spangberg LD; Wahlin BE; Enblad G; Andersson P-O; Kimby E; Smedby KE
- Article: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2024;46:100785Glimelius I; Ekberg S; Smedby KE; Wasterlid T
- Article: ACTA ONCOLOGICA. 2024;63:164-168Ekberg S; Molin D; Pahnke S; Bergstroem F; Branvall E; Smedby KE; Waesterlid T
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2024;204(3):967-975Baech J; Husby S; Trab T; Kragholm K; Brown P; Gorlov JS; Jorgensen JM; Gudbrandsdottir S; Severinsen MT; Gronbaek K; Larsen TS; Wasterlid T; Eloranta S; Smeland KB; Jakobsen LH; El-Galaly TC
- Journal article: ACTA ONCOLOGICA. 2023;62(6):560-564Smedby KE; Waesterlid T; Tham E; Haider Z; Joelsson J; Thorvaldsdottir B; Krstic A; Wahlin BE; Foroughi-Asl H; Karlsson C; Eloranta S; Saft L; Palma M; Kwiecinska A; Hansson L; Osterborg A; Wirta V; Rassidakis G; Sander B; Sonnevi K; Rosenquist R
- Article: FRONTIERS IN ONCOLOGY. 2023;13:1176698Haider Z; Wasterlid T; Spangberg LD; Rabbani L; Jylha C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hagglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
- Article: HEMASPHERE. 2023;7(3):e838Weibull CE; Wasterlid T; Wahlin BE; Andersson P-O; Ekberg S; Lockmer S; Enblad G; Crowther MJ; Kimby E; Smedby KE
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2023;98(1):23-30Radkiewicz C; Bruchfeld JB; Weibull CE; Jeppesen ML; Frederiksen H; Lambe M; Jakobsen L; El-Galaly TC; Smedby KE; Wasterlid T
- Article: FRONTIERS IN ONCOLOGY. 2022;12:984021Ruiz NR; Abd Own S; Smedby KE; Eloranta S; Koch S; Wasterlid T; Krstic A; Boman M
- Article: BRITISH JOURNAL OF CANCER. 2022;127(10):1808-1815Syriopoulou E; Wasterlid T; Lambert PC; Andersson TM-L
- Journal article: ANNALS OF LYMPHOMA. 2022;0(0):0Wästerlid T; Murphy S; Villa D; El-Galaly TC
- Article: BLOOD ADVANCES. 2022;6(8):2657-2666Joelsson J; Wasterlid T; Rosenquist R; Jakobsen LH; El-Galaly TC; Smedby KE; Eloranta S
- Article: EJHAEM. 2021;2(4):774-784Sonnevi K; Ljungqvist M; Joelsson JK; Harrysson S; Wasterlid T; Bernell P; Wahlin BE
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;195(4):552-560Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
- Article: EJHAEM. 2021;2(3):525-529Lundin J; Mulder TA; Kattstrom M; Wasterlid T; Uddevik A; Mellstedt H; Heimersson K; Hansson L; Palma M; Osterborg A
- Journal article: BLOOD CANCER JOURNAL. 2021;11(5):100Wasterlid T; Hasselblom S; Joelsson J; Weibull CE; Rassidakis G; Sander B; Smedby KE
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(3):551-559Wasterlid T; Oren Gradel K; Eloranta S; Glimelius I; El-Galaly TC; Frederiksen H; Smedby KE
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81Sonnevi K; Wasterlid T; Melen CM; Harrysson S; Smedby KE; Wahlin BE
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748Wasterlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(6):652-661Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(4):661-671Jakobsen LH; Ellin F; Smeland KB; Wasterlid T; Christensen JH; Jorgensen JM; Josefsson PL; Ovlisen AK; Holte H; Blaker YN; Grauslund JH; Bjorn J; Molin D; Lagerlof I; Smedby KE; Colvin K; Thanarajasingam G; Maurer MJ; Habermann TM; Song KW; Zhu KY; Gerrie AS; Cheah CY; El-Galaly TC
- Journal article: BLOOD. 2019;134:4113Ellin F; Smeland KB; Wasterlid T; Christensen JH; Jorgensen J; Josefsson PL; Holte H; Blaker YN; Grauslund JH; Bjoern J; Molin D; Lagerlof I; Smedby KEE; Colvin K; Thanarajasingam G; Maurer MJ; Habermann TM; Song K; Zhu KY; Gerrie AS; Cheah CY; El-Galaly TCC; Jakobsen LH
- Article: JOURNAL OF INTERNAL MEDICINE. 2019;285(4):455-468Wasterlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
- Journal article: BLOOD. 2018;132:452Jakobsen LH; Ellin F; Smeland KB; Wasterlid T; Christensen JH; Jorgensen J; Josefsson PL; Holte HJ; Blaker YN; Grauslund JH; Bjorn J; Molin D; Lagerlof I; Smedby KE; Colvin K; Thanarajasingam G; Gerrie AS; Cheah CY; El-Galaly TC
- Journal article: ANNALS OF ONCOLOGY. 2018;29(8):1882-1883Wasterlid T; Biccler JL; Brown PN; Bogsted M; Enblad G; Jorgensen JM; Christensen JH; Wahlin BE; Smedby KE; El-Galaly TC; Jerkeman M
- Journal article: LEUKEMIA & LYMPHOMA. 2017;58(7):1760-1763Wasterlid T; Nordstrom L; Freiburghaus C; Pedersen M; Norgaard P; Gang AO; Brown P; Dictor M; Jerkeman M; Ek S
- Article: HEMATOLOGICAL ONCOLOGY. 2017;35(2):151-157Wasterlid T; Hartman L; Szekely E; Jerkeman M
- Journal article: BLOOD. 2015;126(23):5039Wasterlid T; Nordstrom L; Pedersen M; Norgaard PH; Gang AO; Brown PDN; Jerkeman M; Ek S
- Journal article: BLOOD. 2014;124(21):4427Wasterlid T; Szekely E; Hartman LW; Jerkeman M
- Article: ANNALS OF ONCOLOGY. 2013;24(7):1879-1886Wasterlid T; Brown PN; Hagberg O; Hagberg H; Pedersen LM; D'Amore F; Jerkeman M
- Article: LEUKEMIA & LYMPHOMA. 2011;52(11):2090-2096Wasterlid T; Jonsson B; Hagberg H; Jerkeman M
- Show more
All other publications
- Conference publication: BLOOD. 2022;140:3620-3621Wasterlid T; Warnqvist A; Weibull CE; Wahlin BE; Andersson P-O; Enblad G; Kimby E; Smedby KE
- Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(2):243-261Wasterlid T; Cavelier L; Haferlach C; Konopleva M; Froehling S; Ostling P; Bullinger L; Fioretos T; Smedby KE
- Preprint: RESEARCH SQUARE. 2022Weibull C; Wästerlid T; Wahlin B; Andersson P-OA; Ekberg S; Lockmer S; Enblad G; Crowther M; Kimby E; Smedby KE
- Conference publication: BLOOD. 2021;138:4587Sonnevi K; Ljungqvist M; Joelsson JK; Harrysson S; Wasterlid T; Bernell P; Wahlin B
- Conference publication: BLOOD. 2021;138:2534Radkiewicz C; Bruchfeld JB; Weibull C; Lambe M; Jakobsen LH; El-Galaly TC; Smedby KE; Wästerlid T
- Conference publication: BLOOD. 2019;134:1618Wasterlid T; Rassidakis GZ; Sander B; Smedby KE
- Conference publication: BLOOD. 2018;132:571Wasterlid T; Gradel K; Jerkeman M; Frederiksen H; Smedby KE
- Conference publication: BLOOD. 2017;130Wasterlid T; Biccler JL; Brown PDN; Christensen JH; Enblad G; Jorgensen JM; Smedby KE; El-Galaly TC; Jerkeman M
- Conference publication: HAEMATOLOGICA. 2016;101:403Wasterlid T; Nordstrom L; Pedersen M; Norgaard P; Gang AO; Brown P; Jerkeman M; Ek S
- Conference publication: ANNALS OF ONCOLOGY. 2011;22:190-191Wasterlid T; Jonsson B; Hagberg H; Jerkeman M
Grants
- Epidemiologiska och genetiska studier av lymfom hos äldre för framtida precision i diagnostik och behandlingALF Region Stockholm (Kliniska postdoktorer)1 January 2020 - 1 January 2023
- Genetic studies and evaluation of cell-free tumour DNA for future diagnostic and therapeutic precision in lymphomaÅke Olssons stiftelse
- Magnus Bergvall Foundation
- Genetic studies and evaluation of cell-free tumour DNA for future diagnostic and therapeutic precision in lymphomaSvenska Läkaresällskapet (SLS Projektanslag) (971438)
- Genetic studies and evaluation of cell-free tumour DNA for future diagnostic and therapeutic precision in lymphomaJeanssons Stiftelse
- Epidemiological studies on elderly patients with lymphomaKarolinska Institutet Stiftelser och Fonder
- Epidemiological and genetic studies on lymphoma for future diagnostic and therapeutic precisionÅke Wibergs Stiftelse
- Könsrelaterade skillnader i incidens och överlevnad vid lymfomGunnar Grimfors gåvofond
- Könsrelaterade skillnader i incidens och överlevnad vid lymfomKarolinskas fond för leukemiforskning
Employments
- Affiliated to Research, Department of Medicine, Karolinska Institutet, 2024-2026
- Affiliated to Research, Department of Medicine, Karolinska Institutet, 2017-2026
- Resident in Hematology, Department of Hematology, Karolinska University Hospital, 2017-2023
Degrees and Education
- Docent, Hematology, Karolinska Institutet, 2025
Supervision
Supervision to doctoral degree
- Linn Deleskog Spångberg, 2022-
- Johanna Borg Bruchfeld, Sex-related differences in incidence and outcomes among patients with lymphoma: epidemiological and biological perspectives, https://ki.se/en/people/johanna-borg-bruchfeld, 2021-
- Joel Joelsson, 2019-
Supervision of postdoctoral researcher
- Erik Boberg, 2023-